Cel-Sci Corporation (CVM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cel-Sci Corporation, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.60
+1.91% today
Market cap
$28M
Overall quality
38/100
Kronos AI 30-day
−16.0%
1 of 8 simulated paths end higher
Cel-Sci Corporation (CVM) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $28M. It trades at $1.60, up 1.91% today. Its overall quality score is 38 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is −16.0% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $1.32 (−16.0%) |
| Likely range | −25.1% … +2.1% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
| Profitability | 35 |
| Solvency | 32 |
| Growth | 48 |
| Overall | 38 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.